Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00716105 · ClinicalTrials.gov registry record · NA
Effect of the Level of Dietary Protein on Infant Growth
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 405
- Enrollment target
NCT00716105 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 405 participants.
The verdict
NCT00716105, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 405 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether infants fed a formula with protein levels different than a standard infant formula have similar growth and development.
Interventions
- OTHER Standard infant formula
- OTHER Infant formula with different level of proteins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2008-08 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00716105
The ClinicalTrials.gov registry entry for NCT00716105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard infant formula is the first listed.
NCT00716105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00716105 about?
NCT00716105 is a clinical study titled "Effect of the Level of Dietary Protein on Infant Growth". The purpose of this study is to determine whether infants fed a formula with protein levels different than a standard infant formula have similar growth and development.
What is the current status of trial NCT00716105?
This trial is currently completed. It is a NA study. The enrollment target is 405 participants. The study started on 2008-08. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00716105?
The interventions under investigation include: Standard infant formula (OTHER), Infant formula with different level of proteins (OTHER).
Who is sponsoring clinical trial NCT00716105?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.